2018-2023 Global Primary Ciliary Dyskinesia Market Report (Status and Outlook)

August 2018 | 115 pages | ID: 2383F732B3EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Primary Ciliary Dyskinesia market for 2018-2023.

Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube, and flagella of sperm cells.
There no standardized effective treatment strategies for the condition. Severe fatal respiratory failure can develop; long-term treatment with macrolides such as clarithromycin, erythromycin and azithromycin has been empirically applied for the treatment of primary ciliary dyskinesia in Japan, though controversial due to the effects of the medications.
Over the next five years, LPI(LP Information) projects that Primary Ciliary Dyskinesia will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Primary Ciliary Dyskinesia market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Genetic Testing
• Electron Microscopy

Segmentation by application:

• Hospitals & Clinics
• Research Centers

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• AstraZeneca
• Boehringer Ingelheim
• Novartis
• Teva
• Bayer
• Rotech Healthcare
• Pfizer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Primary Ciliary Dyskinesia market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Primary Ciliary Dyskinesia market by identifying its various subsegments.
• Focuses on the key global Primary Ciliary Dyskinesia players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Primary Ciliary Dyskinesia with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Primary Ciliary Dyskinesia submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Primary Ciliary Dyskinesia Market Size 2013-2023
  2.1.2 Primary Ciliary Dyskinesia Market Size CAGR by Region
2.2 Primary Ciliary Dyskinesia Segment by Type
  2.2.1 Genetic Testing
  2.2.2 Electron Microscopy
2.3 Primary Ciliary Dyskinesia Market Size by Type
  2.3.1 Global Primary Ciliary Dyskinesia Market Size Market Share by Type (2013-2018)
  2.3.2 Global Primary Ciliary Dyskinesia Market Size Growth Rate by Type (2013-2018)
2.4 Primary Ciliary Dyskinesia Segment by Application
  2.4.1 Hospitals & Clinics
  2.4.2 Research Centers
2.5 Primary Ciliary Dyskinesia Market Size by Application
  2.5.1 Global Primary Ciliary Dyskinesia Market Size Market Share by Application (2013-2018)
  2.5.2 Global Primary Ciliary Dyskinesia Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PRIMARY CILIARY DYSKINESIA BY PLAYERS

3.1 Global Primary Ciliary Dyskinesia Market Size Market Share by Players
  3.1.1 Global Primary Ciliary Dyskinesia Market Size by Players (2016-2018)
  3.1.2 Global Primary Ciliary Dyskinesia Market Size Market Share by Players (2016-2018)
3.2 Global Primary Ciliary Dyskinesia Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PRIMARY CILIARY DYSKINESIA BY REGIONS

4.1 Primary Ciliary Dyskinesia Market Size by Regions
4.2 Americas Primary Ciliary Dyskinesia Market Size Growth
4.3 APAC Primary Ciliary Dyskinesia Market Size Growth
4.4 Europe Primary Ciliary Dyskinesia Market Size Growth
4.5 Middle East & Africa Primary Ciliary Dyskinesia Market Size Growth

5 AMERICAS

5.1 Americas Primary Ciliary Dyskinesia Market Size by Countries
5.2 Americas Primary Ciliary Dyskinesia Market Size by Type
5.3 Americas Primary Ciliary Dyskinesia Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Primary Ciliary Dyskinesia Market Size by Countries
6.2 APAC Primary Ciliary Dyskinesia Market Size by Type
6.3 APAC Primary Ciliary Dyskinesia Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Primary Ciliary Dyskinesia by Countries
7.2 Europe Primary Ciliary Dyskinesia Market Size by Type
7.3 Europe Primary Ciliary Dyskinesia Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Primary Ciliary Dyskinesia by Countries
8.2 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Type
8.3 Middle East & Africa Primary Ciliary Dyskinesia Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PRIMARY CILIARY DYSKINESIA MARKET FORECAST

10.1 Global Primary Ciliary Dyskinesia Market Size Forecast (2018-2023)
10.2 Global Primary Ciliary Dyskinesia Forecast by Regions
  10.2.1 Global Primary Ciliary Dyskinesia Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Primary Ciliary Dyskinesia Forecast by Type
10.8 Global Primary Ciliary Dyskinesia Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 Company Details
  11.1.2 Primary Ciliary Dyskinesia Product Offered
  11.1.3 AstraZeneca Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 AstraZeneca News
11.2 Boehringer Ingelheim
  11.2.1 Company Details
  11.2.2 Primary Ciliary Dyskinesia Product Offered
  11.2.3 Boehringer Ingelheim Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Boehringer Ingelheim News
11.3 Novartis
  11.3.1 Company Details
  11.3.2 Primary Ciliary Dyskinesia Product Offered
  11.3.3 Novartis Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Novartis News
11.4 Teva
  11.4.1 Company Details
  11.4.2 Primary Ciliary Dyskinesia Product Offered
  11.4.3 Teva Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Teva News
11.5 Bayer
  11.5.1 Company Details
  11.5.2 Primary Ciliary Dyskinesia Product Offered
  11.5.3 Bayer Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Bayer News
11.6 Rotech Healthcare
  11.6.1 Company Details
  11.6.2 Primary Ciliary Dyskinesia Product Offered
  11.6.3 Rotech Healthcare Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Rotech Healthcare News
11.7 Pfizer
  11.7.1 Company Details
  11.7.2 Primary Ciliary Dyskinesia Product Offered
  11.7.3 Pfizer Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Pfizer News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Primary Ciliary Dyskinesia
Figure Primary Ciliary Dyskinesia Report Years Considered
Figure Market Research Methodology
Figure Global Primary Ciliary Dyskinesia Ma